Our Pricing

Buy Private Weight Loss Injections Online UK

Published on: June 03, 2026

When you buy private weight loss injections online UK through Cured Pharmacy, you access genuine MHRA-licensed treatments including Mounjaro, Wegovy, and Saxenda with transparent upfront pricing and a free clinical consultation completed in under three minutes. Our UK-registered prescribers assess your suitability for treatment, ensuring safe, effective weight management tailored to your individual health profile.

How Weight Loss Injections Work in the UK

Weight loss injections available through UK pharmacies belong to a class of medications called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and blood sugar levels [1]. These treatments work by slowing gastric emptying, increasing feelings of fullness after meals, and reducing hunger signals between meals, making it easier to maintain a calorie deficit.

The most advanced option, Mounjaro (tirzepatide), is the first dual GIP/GLP-1 receptor agonist licensed by the MHRA, activating two complementary pathways rather than one [2]. In the SURMOUNT-1 trial, participants using the highest dose achieved an average 22.5% body weight reduction over 72 weeks, representing a significant advancement in pharmacological weight management [2].

Wegovy (semaglutide) and Saxenda (liraglutide) are single-pathway GLP-1 agonists with established efficacy profiles. The STEP trials demonstrated that semaglutide 2.4mg once weekly produced an average 14.9% weight loss over 68 weeks, whilst liraglutide 3mg daily achieved approximately 8% reduction in the SCALE trials [1][3]. All three medications are prescription-only in the UK and require clinical assessment by a registered prescriber before dispensing.

Mounjaro vs Wegovy vs Saxenda: Clinical Comparison

Mounjaro (tirzepatide) represents the newest generation of weight loss treatment, combining GIP and GLP-1 receptor activation to produce superior weight reduction compared to single-pathway alternatives [2]. Clinical trials show tirzepatide delivers approximately 50% greater weight loss than semaglutide at comparable timeframes, though individual responses vary based on adherence, lifestyle factors, and metabolic profile.

Wegovy (semaglutide) offers once-weekly dosing with a well-established safety profile, having been used in diabetes management for several years before receiving MHRA approval for weight management in 2022 [1]. Saxenda (liraglutide) requires daily injections but has the longest track record of the three medications, with over a decade of clinical use informing prescriber decision-making.

Your suitability for each treatment depends on your medical history, current medications, body mass index, and previous weight loss attempts. UK prescribers at Cured Pharmacy assess factors including cardiovascular risk, thyroid history, and gastrointestinal tolerance when recommending the most appropriate option for your circumstances.

Dosing Schedules and Administration

Mounjaro and Wegovy both use once-weekly subcutaneous injections with pre-filled pens, typically administered on the same day each week at any time. Saxenda requires daily injections, offering more frequent dosing flexibility but requiring consistent daily adherence. All three medications use gradual dose escalation over several weeks to minimise gastrointestinal side effects, with your prescriber determining the optimal maintenance dose based on your response and tolerability.

Eligibility Criteria for Weight Loss Injections UK

NICE guidelines recommend GLP-1 receptor agonists for adults with a body mass index of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. UK prescribers assess your BMI, medical history, previous weight loss attempts, and current health status during the online consultation to determine suitability.

Certain medical conditions preclude the use of weight loss injections, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy and breastfeeding [2][3]. Your prescriber will review your complete medication list to identify potential interactions, particularly with insulin, sulphonylureas, or medications affecting gastric motility.

The online consultation at Cured Pharmacy takes under three minutes and covers essential clinical screening questions. If approved, your prescription is issued by a UK-registered prescriber and dispensed by our GPhC-registered pharmacy, with discreet delivery directly to your address. Treatment requires ongoing clinical monitoring, with prescribers reviewing your progress and adjusting doses as needed to optimise outcomes whilst minimising side effects.

Expected Results and Clinical Outcomes

Clinical trial data provides realistic expectations for weight loss injections, though individual results vary considerably based on baseline weight, adherence, dietary changes, and physical activity levels [1][2]. In the SURMOUNT-1 trial, participants using tirzepatide 15mg achieved average weight reductions of 20.9% at 72 weeks, with some individuals losing significantly more when combined with lifestyle modifications [2].

Weight loss typically begins within the first four weeks of treatment, with the most rapid reduction occurring during months two through six as doses escalate to maintenance levels. The STEP-1 trial showed that semaglutide users lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group who received lifestyle counselling alone [1].

Realistic expectations include gradual, sustained weight reduction rather than rapid drops, with most patients reaching their maximum weight loss between 60 and 72 weeks of continuous treatment. UK prescribers typically recommend continuing treatment for at least 12 weeks to assess response, with NICE guidance suggesting discontinuation if less than 5% weight loss is achieved during this period [4]. Long-term maintenance requires ongoing treatment, as weight regain commonly occurs after medication cessation.

Combining Treatment with Lifestyle Changes

Weight loss injections are most effective when combined with reduced calorie intake and increased physical activity, as demonstrated across all major clinical trials [1][2][3]. UK prescribers recommend establishing sustainable dietary patterns emphasising whole foods, adequate protein intake, and gradual calorie reduction rather than extreme restriction. Regular physical activity, even moderate-intensity walking for 150 minutes weekly, significantly enhances outcomes and improves cardiovascular health markers alongside weight reduction.

Common Side Effects and Management Strategies

Gastrointestinal side effects are the most frequently reported adverse events with GLP-1 receptor agonists, affecting up to 44% of users in clinical trials [1][2]. Nausea, diarrhoea, constipation, and abdominal discomfort typically emerge during dose escalation phases and diminish over two to four weeks as your body adapts to the medication.

Managing side effects involves several practical strategies: eating smaller, more frequent meals; avoiding high-fat foods that slow gastric emptying further; staying well-hydrated; and timing injections to minimise disruption to daily activities. If nausea persists beyond the initial adjustment period, your prescriber may slow the dose escalation schedule or recommend anti-nausea medications as a temporary measure.

Serious adverse events are rare but require immediate medical attention, including severe abdominal pain that may indicate pancreatitis, visual changes, persistent vomiting leading to dehydration, or signs of allergic reaction [2][3]. Your prescriber will discuss warning signs during your consultation and provide clear guidance on when to seek urgent medical care. Regular monitoring through follow-up consultations ensures early identification of any concerning symptoms.

Pricing and Value: Buy Private Weight Loss Injections Online UK

At Cured Pharmacy, transparent upfront pricing means you see costs before completing your consultation, with no hidden fees or surprise charges. Our pricing structure reflects genuine UK-licensed medications dispensed by our GPhC-registered pharmacy under the oversight of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

When you buy private weight loss injections online UK through our service, you benefit from competitive pricing alongside comprehensive clinical support. Treatment costs vary based on your prescribed medication and dose, with options available from £135.00 for Saxenda to £135.00 for Mounjaro. We guarantee lowest prices in the UK market, ensuring you receive genuine MHRA-licensed treatments without the premium pricing often seen at high-street pharmacies.

Your investment includes the medication itself, free online consultation with a UK-registered prescriber, discreet packaging, and access to ongoing clinical support throughout your treatment journey. Unlike some providers who charge separate consultation fees, our transparent pricing model includes all necessary clinical services, making private weight loss treatment accessible and affordable for UK patients seeking effective pharmacological support.

What's Included in Your Treatment Package

Every prescription includes a comprehensive clinical assessment by a UK-registered prescriber, genuine MHRA-licensed medication dispensed from our registered pharmacy, discreet delivery to your specified address, and access to our clinical team for questions or concerns during treatment. We provide clear dosing instructions, injection technique guidance, and ongoing support to optimise your treatment outcomes whilst ensuring safe, appropriate use of your prescribed medication.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management. Clinical guideline [CG189]. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment and lifestyle modifications.